SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for IDEXX LABORATORIES (IDXX) — Nov 1, 2013

IDEXX LABORATORIES INC /DE (IDXX) (CIK 0000874716)
Date: Nov. 1, 2013 · CIK: 0000874716 · Accession: 0000000000-13-060147

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-19271

Date
December 31, 2012
Author
/s/ Jim B. Rosenberg
Form
UPLOAD
Company
IDEXX LABORATORIES INC /DE (IDXX) (CIK 0000874716)

Letter

October 31 , 201 3 Via E -mail Mr. Jonathan W. Ayers Chairman, President and Chief Executive Officer IDEXX Laboratories, Inc. One Idexx Drive, Westbrook , Maine 04092

Re: IDEXX Laboratories, Inc. Form 10 -K for the Fiscal Year Ended December 31, 2012 Filed February 19, 201 3 File No. 000-19271

Dear Mr. Ayers:

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securitie s laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Jim B. Rosenberg

Show Raw Text
October 31 , 201 3

Via E -mail
Mr. Jonathan W. Ayers
Chairman, President and
Chief Executive Officer
IDEXX Laboratories, Inc.
One Idexx  Drive,
Westbrook , Maine  04092

Re:  IDEXX Laboratories, Inc.
 Form 10 -K for the Fiscal Year Ended December 31, 2012
Filed February 19, 201 3
File No. 000-19271

Dear Mr. Ayers:

We have completed our review of your filing.  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securitie s laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing  to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

/s/ Jim B. Rosenberg

Jim B. Rosenberg
Senior Assistant Chief Accountant